共 50 条
- [31] RATES OF TERATOMA AT POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION BY INDUCTION CHEMOTHERAPY REGIMEN FOR GOOD RISK NON-SEMINOMATOUS GERM CELL TUMORS JOURNAL OF UROLOGY, 2011, 185 (04): : E334 - E334
- [32] Study of the conformity of post-chemotherapy retroperitoneal lymph-node dissection (RPLND) to standard recommendations in patients with testicular (T) and primary retroperitoneal (PR) non-seminomatous germ-cell tumor (NSGCT): Impact on outcome. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 402S - 402S
- [38] Post-chemotherapy retroperitoneal lymph node dissection can not be safely omitted in patients with metastatic non-seminomatous germ cell testis cancer JOURNAL OF UROLOGY, 2008, 179 (04): : 176 - 176